# Sisu Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sisu-pharma

- Industry: Pharmaceuticals
- Headquarters: US
- Website: www.sisupharma.com
- Total disclosed funding: $1.7M
- Latest round: Seed (Oct 19, 2020)
- Investors on record: 1

## About

Established in 2019 and based in US, Sisu Pharma operates as a medical drugs producer that focuses on cancer treatment. Dr. Sean O'Brien is the founder and CEO of the company. In October 2017, the company raised USD 1.7 million in seed funding from new investor Viva Ventures Biotech.

The company provides medical drugs for patients with prostate cancer. The company develops HI-LiTe platform. HI-LiTe platform includes heat shock factor 1 (HSF1) and hyperactivation in cancer.

## Funding rounds

- Seed, Oct 19, 2020, $1.7M — Viva Ventures Biotech

## Investors

- Viva Ventures Biotech (https://capitalatlas.ai/funds/viva-ventures-biotech) — Seed